VRTX
Ticker
Vertex
Company
Biopharma
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
40.7%883.9%8.3%-20.6%-52.1%77.9%64.9%46.2%22.5%36.6%49.1%22.1%17.9%10.5%11.7% 10.5%
Revenue Growth QoQ
Gross Margin
86.1%91.1%94.3%81.7%89.3%89.5%87.9%87.6%88.9%86.6%86.8%88.1%88.1%87.9%87.2%86.1% 86.1%
EBITDA Margin
-573.1%-464.3%10.6%2.7%-46.3%-108.4%-39.2%4.2%7.4%23.2%31.3%47.8%38.4%49.9%40.7%-0.2% 36.1%
Operating Margin
-602.6%-485.5%8.1%0.2%-50.3%-119.3%-45.2%0.6%5.0%20.8%28.8%46.0%36.7%48.2%38.8%-2.1% 34.4%
Profit Margin
-630.3%-526.3%2.1%-7.0%-36.7%-127.2%-53.9%-6.6%10.6%68.8%28.3%43.7%30.9%37.2%36.7%-4.9% 31.9%
FCF / EBITDA
77.3%101.2%73.3%485.4%18.3%89.7%101.5%251.7%403.8%166.0%114.5%100.9%82.8%88.1%81.7%3805.4% 84.9%